Dr Vibeke Sorensen Catts
Manager

Dr Vibeke Sorensen Catts

2006    Doctor of Philosophy (Biomedical Science), University of Queensland. Thesis title: Cell death and proliferation in mental disorder.
1999    Bachelor of Science with Honours, Class I (Biochemistry and Molecular Genetics), University of New South Wales. Thesis title: Elucidation of glucocorticoid resistance mechanisms in childhood acute lymphoblastic leukaemia.

Medicine & Health
Centre for Healthy BrainAgeing

Dr Vibeke Catts is the Study Coordinator of the Older Australian Twins Study (OATS), a longitudinal study aiming to determine the genetic and environmental influences on the ageing process, and the extent to which these determinants interact. OATS participants are assessed across multiple research domains: neuropsychological assessment of cognitive function, questionnaires detailing lifestyle, physical and mental health of self and family, blood biochemistry and genetics, and neuroimaging including MRI and PET scans. The study participates in several global consortia and supports the work of several research students at UNSW Sydney.

Dr Catts provides research management to the Centre for Healthy Brain Ageing (CHeBA), including guidance on research governance and liaison with relevant regulatory bodies.

Meet Our Researcher
Click here to read Dr Vibeke Catts's ‘Meet Our Researcher’ interview

Phone
0431812961
Location
Centre for Healthy Brain Ageing (CHeBA) UNSW Medicine, School of Psychiatry Level 1, AGSM (G27) Gate 11, Botany Street UNSW SYDNEY NSW 2052 AUSTRALIA

Publications

  • Book Chapters | 2010
    Catts VS; Catts SV, 2010, 'Psychotomimetic effects of pcp, lsd, and ecstasy: Pharmacological models of schizophrenia?', in Secondary Schizophrenia, pp. 141 - 168, http://dx.doi.org/10.1017/CBO9780511789977.011
  • Journal articles | 2021
    Gustavson DE; Panizzon MS; Kremen WS; Reynolds CA; Pahlen S; Nygaard M; Wod M; Catts VS; Lee T; Gatz M; Franz CE, 2021, 'Genetic and Environmental Influences on Semantic Verbal Fluency Across Midlife and Later Life', Behavior Genetics, vol. 51, pp. 99 - 109, http://dx.doi.org/10.1007/s10519-021-10048-w
    Journal articles | 2020
    Cai HQ; Catts VS; Webster MJ; Galletly C; Liu D; O’Donnell M; Weickert TW; Weickert CS, 2020, 'Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation', Molecular Psychiatry, vol. 25, pp. 761 - 775, http://dx.doi.org/10.1038/s41380-018-0235-x
    Journal articles | 2020
    Cai HQ; Weickert TW; Catts VS; Balzan R; Galletly C; Liu D; O'Donnell M; Shannon Weickert C, 2020, 'Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls', Brain, Behavior, and Immunity, vol. 89, pp. 200 - 208, http://dx.doi.org/10.1016/j.bbi.2020.06.017
    Journal articles | 2020
    Gustavson DE; Panizzon MS; Kremen WS; Reynolds CA; Nygaard M; Wod M; Catts VS; Lee T; Gatz M; Franz CE, 2020, 'Genetic and environmental influences on semantic verbal fluency across midlife and later life', Alzheimer's & Dementia, vol. 16, http://dx.doi.org/10.1002/alz.037410
    Journal articles | 2019
    Jiang J; Thalamuthu A; Koch FC; Liu T; Xu Q; Trollor JN; Ames D; Wright MJ; Catts V; Sachdev PS; Wen W, 2019, 'Cerebral Blood Flow in Community-Based Older Twins Is Moderately Heritable: An Arterial Spin Labeling Perfusion Imaging Study', Frontiers in Aging Neuroscience, vol. 11, pp. 169 - 169, http://dx.doi.org/10.3389/fnagi.2019.00169
    Journal articles | 2019
    Koncz R; Thalamuthu A; Wen W; Catts VS; Rowe CC; Sachdev PS, 2019, 'THE HERITABILITY OF AMYLOID DEPOSITION AND ITS SHARED GENETIC BASIS WITH SMALL VESSEL DISEASE IN THE BRAINS OF OLDER PEOPLE', Alzheimer's & Dementia, vol. 15, pp. P1633 - P1634, http://dx.doi.org/10.1016/j.jalz.2019.06.4875
    Journal articles | 2018
    Hagihara H; Catts VS; Katayama Y; Shoji H; Takagi T; Huang FL; Nakao A; Mori Y; Huang KP; Ishii S; Graef IA; Nakayama KI; Shannon Weickert C; Miyakawa T, 2018, 'Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders', Neuropsychopharmacology, vol. 43, pp. 459 - 468, http://dx.doi.org/10.1038/npp.2017.167
    Journal articles | 2018
    Tsai SY; Catts VS; Fullerton JM; Corley SM; Fillman SG; Shannon Weickert C, 2018, 'Nuclear Receptors and Neuroinflammation in Schizophrenia', Mol Neuropsychiatry, vol. 3, pp. 181 - 191, http://dx.doi.org/10.1159/000485565
    Journal articles | 2018
    Yan J; Winterford CM; Catts VS; Pat BK; Pender MP; McCombe PA; Greer JM, 2018, 'Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis', Journal of Neuroimmunology, vol. 320, pp. 111 - 116, http://dx.doi.org/10.1016/j.jneuroim.2018.04.002
    Journal articles | 2018
    Mohan A; Thalamuthu A; Mather KA; Zhang Y; Catts VS; Weickert CS; Sachdev PS, 2018, 'Differential expression of synaptic and interneuron genes in the aging human prefrontal cortex', Neurobiology of Aging, vol. 70, pp. 194 - 202, http://dx.doi.org/10.1016/j.neurobiolaging.2018.06.011
    Journal articles | 2018
    Zhang Y; Catts VS; Shannon Weickert C, 2018, 'Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia', Australian and New Zealand Journal of Psychiatry, vol. 52, pp. 690 - 698, http://dx.doi.org/10.1177/0004867417728805
    Journal articles | 2017
    Glass LJ; Sinclair D; Boerrigter D; Naude K; Fung SJ; Brown D; Catts VS; Tooney P; O'Donnell M; Lenroot R; Galletly C; Liu D; Weickert TW; Shannon Weickert C, 2017, 'Brain antibodies in the cortex and blood of people with schizophrenia and controls', Translational Psychiatry, vol. 7, http://dx.doi.org/10.1038/tp.2017.134
    Journal articles | 2017
    Boerrigter D; Weickert TW; Lenroot R; O'Donnell M; Galletly C; Liu D; Burgess M; Cadiz R; Jacomb I; Catts VS; Fillman SG; Weickert CS, 2017, 'Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder', Journal of Neuroinflammation, vol. 14, http://dx.doi.org/10.1186/s12974-017-0962-y
    Journal articles | 2017
    Burgess M; Boerrigter D; Weickert T; Lenroot R; O’Donnell M; Galletly C; Liu D; Cadiz R; Jacomb I; Catts VS; Weickert CS, 2017, 'SA6. How Reliable are Peripheral Biomarkers of Inflammation in Schizophrenia?', Schizophrenia Bulletin, vol. 43, pp. S114 - S115, http://dx.doi.org/10.1093/schbul/sbx023.005
    Journal articles | 2017
    Shannon Weickert C; Cai H; Glass L; Webster M; Boerrigter D; Sinclair D; Catts V, 2017, '767. Evidence for Blood-Brain Barrier Disruption and Antibody Presence in Brains of People with Schizophrenia', Biological Psychiatry, vol. 81, pp. S311 - S312, http://dx.doi.org/10.1016/j.biopsych.2017.02.834
    Journal articles | 2016
    Zhang Y; Catts VS; Sheedy D; McCrossin T; Kril JJ; Shannon Weickert C, 2016, 'Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation', Translational Psychiatry, vol. 6, http://dx.doi.org/10.1038/tp.2016.238
    Journal articles | 2016
    Catts VS; Lai YL; Weickert CS; Weickert TW; Catts SV, 2016, 'A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?', Biological Psychology, vol. 116, pp. 57 - 67, http://dx.doi.org/10.1016/j.biopsycho.2015.10.013
    Journal articles | 2016
    Fillman SG; Weickert TW; Lenroot RK; Catts SV; Bruggemann JM; Catts VS; Weickert CS, 2016, 'Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume', Molecular Psychiatry, vol. 21, pp. 1090 - 1098, http://dx.doi.org/10.1038/mp.2015.90
    Journal articles | 2016
    2016, 'Speaker 1: Vibeke Catts, Australia', International Journal of Neuropsychopharmacology, vol. 19, pp. 36 - 36, http://dx.doi.org/10.1093/ijnp/pyw042.092
    Journal articles | 2015
    Joshi D; Catts VS; Olaya JC; Shannon Weickert C, 2015, 'Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: A post-mortem brain mRNA study', npj Schizophrenia, vol. 1, pp. 14004 - 14004, http://dx.doi.org/10.1038/npjschz.2014.4
    Journal articles | 2015
    Catts VS; Derminio D; Hahn CG; Shannon Weickert C, 2015, 'Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia', npj Schizophrenia, vol. 1, pp. 15037 - 15037, http://dx.doi.org/10.1038/npjschz.2015.37
    Journal articles | 2014
    Wong J; Fillman SG; Fung SJ; Catts VS; Shannon Weickert C, 2014, 'Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation', Australian New Zealand Journal fo Psychiatry, vol. 48, pp. 722 - 734, http://dx.doi.org/10.1177/0004867414531078
    Journal articles | 2014
    Fillman SG; Lenroot R; Bruggemann J; Catts V; Catts S; O'Donnell M; Shannon-Weickert C; Weickert T, 2014, 'Poster #S26 WHITE BLOOD CELL LEVELS ARE RELATED TO POOR SOCIAL FUNCTIONING AND REDUCED INSULA, AMYGDALA, AND NUCLEUS ACCUMBENS VOLUMES IN A SUBGROUP OF PEOPLE WITH SCHIZOPHRENIA', Schizophrenia Research, vol. 153, pp. S97 - S97, http://dx.doi.org/10.1016/s0920-9964(14)70305-6
    Journal articles | 2013
    Weickert CS; Fung SJ; Catts VS; Schofield PR; Allen KM; Moore LT; Newell KA; Pellen D; Huang XF; Catts SV; Weickert TW, 2013, 'Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia', Molecular Psychiatry, vol. 18, pp. 1185 - 1192, http://dx.doi.org/10.1038/mp.2012.137
    Journal articles | 2013
    Yan J; Catts VS; Chan A; McCombe PA, 2013, 'A simple and reliable immunohistochemical method for colocalization of 2 antigens in the same cells of paraffin-embedded tissues', Applied Immunohistochemistry and Molecular Morphology, vol. 21, pp. 471 - 477, http://dx.doi.org/10.1097/PAI.0b013e3182795710
    Journal articles | 2012
    Catts VS; Shannon Weickert C, 2012, 'Gene expression analysis implicates a death receptor pathway in schizophrenia pathology', PLoS One, vol. 7, pp. Article number e35511, http://dx.doi.org/10.1371/journal.pone.0035511
    Journal articles | 2012
    Catts VS; Catts SV; Jablensky A; Chandler D; Shannon Weickert C; Lavin M, 2012, 'Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia.', World Journal of Biological Psychiatry, vol. 13, pp. 114 - 125, http://dx.doi.org/10.3109/15622975.2011.565073
    Journal articles | 2012
    Lutze-Mann LH; Wijenayake N; Hovey E; Catts VS, 2012, 'PSYCHOTROPIC DRUG REPOSITIONING FOR THE TREATMENT OF GLIOBLASTOMA', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 8, pp. 64 - 65, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2010
    Wiklund ED; Catts VS; Catts SV; Ng TF; Whitaker NJ; Brown AJ; Lutze-Mann L, 2010, 'Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target.', International Journal of Cancer, vol. 126, pp. 28 - 40, http://dx.doi.org/10.1002/ijc.24813
    Journal articles | 2010
    Colditz MJ; Catts VS; Al-Menhali N; Osborne GW; Bartlett PF; Coulson EJ, 2010, 'P75 neurotrophin receptor regulates basal and fluoxetine-stimulated hippocampal neurogenesis', Experimental Brain Research, vol. 200, pp. 161 - 167, http://dx.doi.org/10.1007/s00221-009-1947-6
    Journal articles | 2008
    Catts VS; Catts SV; O'Toole BI; Frost ADJ, 2008, 'Cancer incidence in patients with schizophrenia and their first-degree relatives - A meta-analysis', Acta Psychiatrica Scandinavica, vol. 117, pp. 323 - 336, http://dx.doi.org/10.1111/j.1600-0447.2008.01163.x
    Journal articles | 2008
    Catts VS; Al-Menhali N; Burne THJ; Colditz MJ; Coulson EJ, 2008, 'The p75 neurotrophin receptor regulates hippocampal neurogenesis and related behaviours', European Journal of Neuroscience, vol. 28, pp. 883 - 892, http://dx.doi.org/10.1111/j.1460-9568.2008.06390.x
    Journal articles | 2006
    Naiker DV; Catts SV; Catts VS; Bedi KS; Bryan-Lluka LJ, 2006, 'Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat', European Journal of Pharmacology, vol. 540, pp. 87 - 90, http://dx.doi.org/10.1016/j.ejphar.2006.04.048
    Journal articles | 2006
    Catts VS; Catts SV; Mcgrath J; Feron F; Mclean D; Coulson E; Lutze-Mann L, 2006, 'Apoptosis and schizophrenia: A pilot study based on dermal fibroblast cell lines', Schizophrenia Research, vol. 84, pp. 20 - 28, http://dx.doi.org/10.1016/j.schres.2006.03.016
    Journal articles | 2001
    Catts VS; Haber M; Norris MD; Lutze-Mann L; Lock RB, 2001, 'High Level resistance to Glucocorticoids, assosiated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance', Leukemia, vol. 15, pp. 929 - 935, http://dx.doi.org/10.1038/sj.leu.2402128
    Journal articles | 2000
    Catts VS; Catts SV, 2000, 'Apoptosis and schizophrenia: Is the tumour suppressor gene,p53, a candidate susceptibility gene?', Schizophrenia Research, vol. 41, pp. 405 - 415, http://dx.doi.org/10.1016/S0920-9964(99)00077-8
    Book Chapters | 2010
    Catts VS; Catts SV, 2010, 'Psychotomimetic effects of pcp, lsd, and ecstasy: Pharmacological models of schizophrenia?', in Secondary Schizophrenia, pp. 141 - 168, http://dx.doi.org/10.1017/CBO9780511789977.011
  • Conference Abstracts | 2019
    Mohan A; Thalamuthu A; Mather K; Catts VS; Sachdev PS, 2019, 'Differential expression of neuroinflammatory, neurotransmission-related and synaptic genes across 10 regions of the aging human brain: a microarray study [Poster Abstract P3-141]', in Alzheimer's & Dementia, Elsevier BV, Los Angeles, CA, USA, Vol. 15, pp. P985 - P986, presented at Alzheimer's Association International Conference (AAIC) 2019, Los Angeles, CA, USA, 14 July 2019 - 16 July 2019, http://dx.doi.org/10.1016/j.jalz.2019.06.3169
    Conference Abstracts | 2018
    Mohan A; Thalamuthu A; Mather K; Zhang Y; Catts VS; Weickert CS; Sachdev PS, 2018, 'Differential expression of synaptic and interneuron genes in the aging human prefrontal cortex [Abstract O5-04-06]', in Alzheimer's & Dementia, Elsevier BV, Chicago, USA, Vol. 14, pp. P1654 - P1655, presented at Alzheimer’s Association International Conference (AAIC) 2018, Chicago, USA, 22 July 2018 - 26 July 2018, http://dx.doi.org/10.1016/j.jalz.2018.06.3018
    Conference Papers | 2017
    Weickert CS; Cai H; Glass L; Webster M; Boerrigter D; Sinclair D; Catts V, 2017, 'Evidence for Blood-Brain Barrier Disruption and Antibody Presence in Brains of People with Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, San Diego, CA, pp. S311 - S312, presented at 72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), San Diego, CA, 18 May 2017 - 20 May 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400348700764&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Burgess M; Boerrigter D; Weickert T; Lenroot R; O'Donnell M; Galletly C; Liu D; Cadiz R; Jacomb I; Catts VS; Weickert CS, 2017, 'HOW RELIABLE ARE PERIPHERAL BIOMARKERS OF INFLAMMATION IN SCHIZOPHRENIA?', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, San Diego, CA, Vol. 43, pp. S114 - S115, presented at 16th International Congress on Schizophrenia Research (ICOSR), San Diego, CA, 24 March 2017 - 28 March 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397126200310&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    O'Donnell P; Ivanova S; Catts VS; Zhang Y; Fillman SG; Wong J; Fung SJ; Weickert CS, 2016, 'Relationship between inflammatory cytokines, oxidative stress and astrogliosis markers and prefrontal grey matter volume in schizophrenia subgroups', in INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, OXFORD UNIV PRESS, Seoul, SOUTH KOREA, Vol. 19, pp. 36 - 36, presented at 30th World Congress of the International-College-of-Neuropsychopharmacology (CINP), Seoul, SOUTH KOREA, 03 July 2016 - 07 July 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383917600090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Shannon-Weickert C; Fung SJ; Joshi D; Fillman SG; Catts VS, 2014, 'INCREASED WHITE MATTER NEURON DENSITY IS RELATED TO HIGH NEUROINFLAMMATION IN PEOPLE WITH SCHIZOPHRENIA', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, pp. S27 - S27, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000416107900070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Wijenayake N; Fernandez HR; Catts VS; Whitaker NJ; Lutze-Mann LH, 2013, 'Efficacy and potential mechanisms of psychotropic drugs and statins in the treatment of glioblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Washington, DC, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-5549
    Conference Papers | 2012
    Derminio DS; Catts VS; Rothwell A; Moore L; Vella N; Vercammen A; Catts SV; Weickert TW; Weickert CS, 2012, 'Increased Autoantibodies Against Brain Tissue in Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, Philadelphia, PA, pp. 53S - 53S, presented at 67th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry, Philadelphia, PA, 03 May 2012 - 05 May 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302466000172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2012
    Catts VS; Fung S; Newell K; Huang X-F; Weickert CS, 2012, 'SHEDDING LIGHT ON THE MOLECULAR BASIS FOR NMDAR HYPOFUNCTION IN SCHIZOPHRENIA', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, Vol. 136, pp. S81 - S81, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209842101004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Catts VS; Fung S; Allen K; Huang XF; Weickert CS, 2011, 'INCREASED EXPRESSION OF APRIL (TNFSF13) IN DORSOLATERAL PREFRONTAL CORTEX FROM PATIENTS WITH SCHIZOPHRENIA MAY CONTRIBUTE TO ABERRANT NEUROPLASTICITY', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, Colorado Springs, CO, pp. 187 - 188, presented at 13th International Congress on Schizophrenia Research (ICSR), Colorado Springs, CO, 02 April 2011 - 06 April 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287746000527&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Posters | 2011
    Catts VS; Shannon Weickert C, 2011, 'Altered expression of apoptosis-associated messenger RNAs in prefrontal cortex from patients with schizophrenia', online, pp. 118 - 118, presented at Australian Neuroscience Society 31st Annual Meeting, Auckland, 31 January 2011 - 03 February 2011
    Conference Papers | 2010
    Catts V; Weickert CS, 2010, 'INCREASED EXPRESSION OF APRIL (TNFSF13) IN PREFRONTAL GREY MATTER FROM PATIENTS WITH SCHIZOPHRENIA', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, INFORMA HEALTHCARE, pp. A33 - A33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282954700088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Catts V; Catts S; Jablensky A; Chandler D; Weickert CS; Lavin M, 2010, 'GENOMIC STABILITY AND DNA REPAIR IN LYMPHOBLASTS FROM PATIENTS WITH SCHIZOPHRENIA', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, INFORMA HEALTHCARE, pp. A33 - A33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282954700089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Other | 2008
    Catts VS; Catts SV; O'Toole BI; Frost ADJ, 2008, Reply, http://dx.doi.org/10.1111/j.1600-0447.2008.01236.x
    Conference Papers | 2005
    Catts VS; Wiklund ED; Catts SV; Lutze-Mann LH, 2005, 'No in vitro anti-cancer effect of antipsychotic drugs at doses used in the psychiatric clinic', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, Savannah, GA, pp. 230 - 230, presented at 10th International Congress on Schizophrenia Research, Savannah, GA, 02 April 2005 - 06 April 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000244506600081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2003
    Catts VS; Catts SV; Fernandez HR; Lutze-Mann LH, 2003, 'CDNA microarray assessment of MRNA degradation in postmortem brain tissue', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, COLORADO SPINGS, COLORADO, pp. 60 - 61, presented at 9th International Congress on Schizophrenia Research, COLORADO SPINGS, COLORADO, 29 March 2003 - 02 April 2003, http://dx.doi.org/10.1016/S0920-9964(03)80565-0
    Preprints |
    Hagihara H; Catts VS; Katayama Y; Takagi T; Huang FL; Huang K-P; Ishii S; Graef IA; Crabtree GR; Nakayama KI; Weickert CS; Miyakawa T, Lower brain pH as a shared endophenotype of psychotic disorders, http://dx.doi.org/10.1101/083550
    Journal articles | 2021
    Gustavson DE; Panizzon MS; Kremen WS; Reynolds CA; Pahlen S; Nygaard M; Wod M; Catts VS; Lee T; Gatz M; Franz CE, 2021, 'Genetic and Environmental Influences on Semantic Verbal Fluency Across Midlife and Later Life', Behavior Genetics, vol. 51, pp. 99 - 109, http://dx.doi.org/10.1007/s10519-021-10048-w
    Journal articles | 2020
    Cai HQ; Weickert TW; Catts VS; Balzan R; Galletly C; Liu D; O'Donnell M; Shannon Weickert C, 2020, 'Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls', Brain, Behavior, and Immunity, vol. 89, pp. 200 - 208, http://dx.doi.org/10.1016/j.bbi.2020.06.017
    Journal articles | 2020
    Cai HQ; Catts VS; Webster MJ; Galletly C; Liu D; O’Donnell M; Weickert TW; Weickert CS, 2020, 'Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation', Molecular Psychiatry, vol. 25, pp. 761 - 775, http://dx.doi.org/10.1038/s41380-018-0235-x
    Journal articles | 2020
    Gustavson DE; Panizzon MS; Kremen WS; Reynolds CA; Nygaard M; Wod M; Catts VS; Lee T; Gatz M; Franz CE, 2020, 'Genetic and environmental influences on semantic verbal fluency across midlife and later life', Alzheimer's & Dementia, vol. 16, http://dx.doi.org/10.1002/alz.037410
    Journal articles | 2019
    Jiang J; Thalamuthu A; Koch FC; Liu T; Xu Q; Trollor JN; Ames D; Wright MJ; Catts V; Sachdev PS; Wen W, 2019, 'Cerebral Blood Flow in Community-Based Older Twins Is Moderately Heritable: An Arterial Spin Labeling Perfusion Imaging Study', Frontiers in Aging Neuroscience, vol. 11, pp. 169 - 169, http://dx.doi.org/10.3389/fnagi.2019.00169
    Journal articles | 2019
    Koncz R; Thalamuthu A; Wen W; Catts VS; Rowe CC; Sachdev PS, 2019, 'THE HERITABILITY OF AMYLOID DEPOSITION AND ITS SHARED GENETIC BASIS WITH SMALL VESSEL DISEASE IN THE BRAINS OF OLDER PEOPLE', Alzheimer's & Dementia, vol. 15, pp. P1633 - P1634, http://dx.doi.org/10.1016/j.jalz.2019.06.4875
    Journal articles | 2018
    Mohan A; Thalamuthu A; Mather KA; Zhang Y; Catts VS; Weickert CS; Sachdev PS, 2018, 'Differential expression of synaptic and interneuron genes in the aging human prefrontal cortex', Neurobiology of Aging, vol. 70, pp. 194 - 202, http://dx.doi.org/10.1016/j.neurobiolaging.2018.06.011
    Journal articles | 2018
    Hagihara H; Catts VS; Katayama Y; Shoji H; Takagi T; Huang FL; Nakao A; Mori Y; Huang KP; Ishii S; Graef IA; Nakayama KI; Shannon Weickert C; Miyakawa T, 2018, 'Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders', Neuropsychopharmacology, vol. 43, pp. 459 - 468, http://dx.doi.org/10.1038/npp.2017.167
    Journal articles | 2018
    Tsai SY; Catts VS; Fullerton JM; Corley SM; Fillman SG; Shannon Weickert C, 2018, 'Nuclear Receptors and Neuroinflammation in Schizophrenia', Mol Neuropsychiatry, vol. 3, pp. 181 - 191, http://dx.doi.org/10.1159/000485565
    Journal articles | 2018
    Zhang Y; Catts VS; Shannon Weickert C, 2018, 'Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia', Australian and New Zealand Journal of Psychiatry, vol. 52, pp. 690 - 698, http://dx.doi.org/10.1177/0004867417728805
    Journal articles | 2018
    Yan J; Winterford CM; Catts VS; Pat BK; Pender MP; McCombe PA; Greer JM, 2018, 'Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis', Journal of Neuroimmunology, vol. 320, pp. 111 - 116, http://dx.doi.org/10.1016/j.jneuroim.2018.04.002
    Journal articles | 2017
    Boerrigter D; Weickert TW; Lenroot R; O'Donnell M; Galletly C; Liu D; Burgess M; Cadiz R; Jacomb I; Catts VS; Fillman SG; Weickert CS, 2017, 'Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder', Journal of Neuroinflammation, vol. 14, http://dx.doi.org/10.1186/s12974-017-0962-y
    Journal articles | 2017
    Glass LJ; Sinclair D; Boerrigter D; Naude K; Fung SJ; Brown D; Catts VS; Tooney P; O'Donnell M; Lenroot R; Galletly C; Liu D; Weickert TW; Shannon Weickert C, 2017, 'Brain antibodies in the cortex and blood of people with schizophrenia and controls', Translational Psychiatry, vol. 7, http://dx.doi.org/10.1038/tp.2017.134
    Journal articles | 2017
    Burgess M; Boerrigter D; Weickert T; Lenroot R; O’Donnell M; Galletly C; Liu D; Cadiz R; Jacomb I; Catts VS; Weickert CS, 2017, 'SA6. How Reliable are Peripheral Biomarkers of Inflammation in Schizophrenia?', Schizophrenia Bulletin, vol. 43, pp. S114 - S115, http://dx.doi.org/10.1093/schbul/sbx023.005
    Journal articles | 2017
    Shannon Weickert C; Cai H; Glass L; Webster M; Boerrigter D; Sinclair D; Catts V, 2017, '767. Evidence for Blood-Brain Barrier Disruption and Antibody Presence in Brains of People with Schizophrenia', Biological Psychiatry, vol. 81, pp. S311 - S312, http://dx.doi.org/10.1016/j.biopsych.2017.02.834
    Journal articles | 2016
    Zhang Y; Catts VS; Sheedy D; McCrossin T; Kril JJ; Shannon Weickert C, 2016, 'Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation', Translational Psychiatry, vol. 6, http://dx.doi.org/10.1038/tp.2016.238
    Journal articles | 2016
    Catts VS; Lai YL; Weickert CS; Weickert TW; Catts SV, 2016, 'A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?', Biological Psychology, vol. 116, pp. 57 - 67, http://dx.doi.org/10.1016/j.biopsycho.2015.10.013
    Journal articles | 2016
    Fillman SG; Weickert TW; Lenroot RK; Catts SV; Bruggemann JM; Catts VS; Weickert CS, 2016, 'Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume', Molecular Psychiatry, vol. 21, pp. 1090 - 1098, http://dx.doi.org/10.1038/mp.2015.90
    Journal articles | 2016
    2016, 'Speaker 1: Vibeke Catts, Australia', International Journal of Neuropsychopharmacology, vol. 19, pp. 36 - 36, http://dx.doi.org/10.1093/ijnp/pyw042.092
    Journal articles | 2015
    Joshi D; Catts VS; Olaya JC; Shannon Weickert C, 2015, 'Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: A post-mortem brain mRNA study', npj Schizophrenia, vol. 1, pp. 14004 - 14004, http://dx.doi.org/10.1038/npjschz.2014.4
    Journal articles | 2015
    Catts VS; Derminio D; Hahn CG; Shannon Weickert C, 2015, 'Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia', npj Schizophrenia, vol. 1, pp. 15037 - 15037, http://dx.doi.org/10.1038/npjschz.2015.37
    Journal articles | 2014
    Wong J; Fillman SG; Fung SJ; Catts VS; Shannon Weickert C, 2014, 'Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation', Australian New Zealand Journal fo Psychiatry, vol. 48, pp. 722 - 734, http://dx.doi.org/10.1177/0004867414531078
    Journal articles | 2014
    Fillman SG; Lenroot R; Bruggemann J; Catts V; Catts S; O'Donnell M; Shannon-Weickert C; Weickert T, 2014, 'Poster #S26 WHITE BLOOD CELL LEVELS ARE RELATED TO POOR SOCIAL FUNCTIONING AND REDUCED INSULA, AMYGDALA, AND NUCLEUS ACCUMBENS VOLUMES IN A SUBGROUP OF PEOPLE WITH SCHIZOPHRENIA', Schizophrenia Research, vol. 153, pp. S97 - S97, http://dx.doi.org/10.1016/s0920-9964(14)70305-6
    Journal articles | 2013
    Weickert CS; Fung SJ; Catts VS; Schofield PR; Allen KM; Moore LT; Newell KA; Pellen D; Huang XF; Catts SV; Weickert TW, 2013, 'Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia', Molecular Psychiatry, vol. 18, pp. 1185 - 1192, http://dx.doi.org/10.1038/mp.2012.137
    Journal articles | 2013
    Yan J; Catts VS; Chan A; McCombe PA, 2013, 'A simple and reliable immunohistochemical method for colocalization of 2 antigens in the same cells of paraffin-embedded tissues', Applied Immunohistochemistry and Molecular Morphology, vol. 21, pp. 471 - 477, http://dx.doi.org/10.1097/PAI.0b013e3182795710
    Journal articles | 2012
    Lutze-Mann LH; Wijenayake N; Hovey E; Catts VS, 2012, 'PSYCHOTROPIC DRUG REPOSITIONING FOR THE TREATMENT OF GLIOBLASTOMA', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 8, pp. 64 - 65, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Catts VS; Catts SV; Jablensky A; Chandler D; Shannon Weickert C; Lavin M, 2012, 'Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia.', World Journal of Biological Psychiatry, vol. 13, pp. 114 - 125, http://dx.doi.org/10.3109/15622975.2011.565073
    Journal articles | 2012
    Catts VS; Shannon Weickert C, 2012, 'Gene expression analysis implicates a death receptor pathway in schizophrenia pathology', PLoS One, vol. 7, pp. Article number e35511, http://dx.doi.org/10.1371/journal.pone.0035511
    Journal articles | 2010
    Wiklund ED; Catts VS; Catts SV; Ng TF; Whitaker NJ; Brown AJ; Lutze-Mann L, 2010, 'Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target.', International Journal of Cancer, vol. 126, pp. 28 - 40, http://dx.doi.org/10.1002/ijc.24813
    Journal articles | 2010
    Colditz MJ; Catts VS; Al-Menhali N; Osborne GW; Bartlett PF; Coulson EJ, 2010, 'P75 neurotrophin receptor regulates basal and fluoxetine-stimulated hippocampal neurogenesis', Experimental Brain Research, vol. 200, pp. 161 - 167, http://dx.doi.org/10.1007/s00221-009-1947-6
    Journal articles | 2008
    Catts VS; Catts SV; O'Toole BI; Frost ADJ, 2008, 'Cancer incidence in patients with schizophrenia and their first-degree relatives - A meta-analysis', Acta Psychiatrica Scandinavica, vol. 117, pp. 323 - 336, http://dx.doi.org/10.1111/j.1600-0447.2008.01163.x
    Journal articles | 2008
    Catts VS; Al-Menhali N; Burne THJ; Colditz MJ; Coulson EJ, 2008, 'The p75 neurotrophin receptor regulates hippocampal neurogenesis and related behaviours', European Journal of Neuroscience, vol. 28, pp. 883 - 892, http://dx.doi.org/10.1111/j.1460-9568.2008.06390.x
    Journal articles | 2006
    Catts VS; Catts SV; Mcgrath J; Feron F; Mclean D; Coulson E; Lutze-Mann L, 2006, 'Apoptosis and schizophrenia: A pilot study based on dermal fibroblast cell lines', Schizophrenia Research, vol. 84, pp. 20 - 28, http://dx.doi.org/10.1016/j.schres.2006.03.016
    Journal articles | 2006
    Naiker DV; Catts SV; Catts VS; Bedi KS; Bryan-Lluka LJ, 2006, 'Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat', European Journal of Pharmacology, vol. 540, pp. 87 - 90, http://dx.doi.org/10.1016/j.ejphar.2006.04.048
    Journal articles | 2001
    Catts VS; Haber M; Norris MD; Lutze-Mann L; Lock RB, 2001, 'High Level resistance to Glucocorticoids, assosiated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance', Leukemia, vol. 15, pp. 929 - 935, http://dx.doi.org/10.1038/sj.leu.2402128
    Journal articles | 2000
    Catts VS; Catts SV, 2000, 'Apoptosis and schizophrenia: Is the tumour suppressor gene,p53, a candidate susceptibility gene?', Schizophrenia Research, vol. 41, pp. 405 - 415, http://dx.doi.org/10.1016/S0920-9964(99)00077-8

Awards

2013    Participant of the 2013 Theo Murphy High Flyers Think Tank “Inspiring smarter brain research in Australia”, hosted by the Australian Academy of Science, Melbourne
2011    Dean’s Rising Star Award, Faculty of Medicine, University of New South Wales
2007    Young Investigator Award, International Congress on Schizophrenia Research
2001    Australian Postgraduate Award

Grants

University of New South Wales Gold Star (2014) Is the blood brain barrier compromised in schizophrenia. $40,000. with C Shannon Weickert, M Webster, S Fillman, TW Weickert.
Schizophrenia Research Institute (2013) Neurobiology of cortical thinning in schizophrenia. $16,100. with C Shannon Weickert, Y Zhang, K Newell & N Matosin.
UNSW Major Research Equipment & Infrastructure Scheme (2012) xCELLigence DP Real Time Cell Analysis (RTCA) System. $65,000. with J Fullerton, K Sidhu & C Shannon Weickert.
Cure Cancer Australia (2011) The anti-cancer effects of cholesterol trafficking and synthesis inhibitors as co-drugs in an in vivo glioblastoma multiforme model. AU$90,000. with LH Lutze-Mann, M Morris, E Hovey & M Lavin.
The Stanley Medical Research Institute (2009-2011). FAS-cinating changes in a death receptor pathway in schizophrenia. US$140,607. with C Shannon Weickert.
Rebecca L. Cooper Medical Research Foundation (2006). Establishment of the Neuroplasticity Facility for Psychotic Disorders, Royal Brisbane and Women’s Hospital. $18,000. with SV Catts & GN Elston.
Rebecca L. Cooper Medical Research Foundation (2003) Morphological studies of post-mortem brain tissue in schizophrenia. $14,150. with SV Catts, KD Bedi & GN Elston.
Rebecca L. Cooper Medical Research Foundation (2002) A functional genomics centre for psychotic disorders. $14,203. with LH Lutze-Mann & SV Catts.
Rebecca L. Cooper Medical Research Foundation (2001) Molecular genetic investigations of the causes of schizophrenia. $15,000. with LH Lutze-Mann & SV Catts.

Media

As part of my work with the Older Australian Twins Study (OATS), I have provided support to investigators, staff and students, to facilitate their research. Two Independent Learning Project students under my supervision has investigated longitudinal changes in cognitive function and exploring the factors that contribute to cognitive decline in older age.

Prior to joining the Centre for Healthy Brain Ageing (CHeBA), I held a Post-Doctoral appointment at Neuroscience Research Australia, where I researched molecular and cellular pathology in blood and postmortem brain tissue from individuals with schizophrenia. During my post-doc in the Schizophrenia Research Laboratory, I supervised four higher degree students. 

In collaboration with Professor Lutze-Mann, School of Biotechnology and Biomolecular Sciences, UNSW, I led an investigation of antipsychotic drugs as potential treatments for glioblastoma. It has been noted that patients with schizophrenia have a lower incidence of cancer in comparison with the overall population, which may be attributable to antipsychotic drugs used to manage schizophrenia. We found that antipsychotic drugs preferentially kill cancer cells grown in the laboratory and, since the drugs have the capacity to cross the blood-brain barrier, we tested their potential to be used as chemotherapeutics for brain tumours in a rodent model. The work was supported by a grant by Cure Cancer Australia and the work of two PhD candidates.